NEW YORK (GenomeWeb News) – Dutch molecular diagnostics company GenDx announced today that Qiagen has granted it non-exclusive rights for the worldwide distribution for Qiagen's LongRange PCR kit in combination with GenDx's SBTexcellerator reagents for high-resolution HLA typing.

The agreement covers both direct distribution by GenDx as well as third-party distribution.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.